Preoperative ultra-rapid opiate detoxification for the treatment of post-operative surgical pain

被引:2
作者
Blum, James M. [1 ]
Biel, Sarang S. [2 ]
Hilliard, Paul E. [2 ]
Jutkiewicz, Emily M. [3 ]
机构
[1] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA
[2] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
OPIOID ANTAGONIST DETOXIFICATION; INDUCED HYPERALGESIA; ANESTHESIA; NALOXONE; NALTREXONE; WITHDRAWAL; MORPHINE; TOLERANCE; ANALGESIA; POTENCY;
D O I
10.1016/j.mehy.2015.02.008
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Over the past two decades, the prescription of high dose opiate therapy has continued to accelerate in an attempt to treat patients with chronic pain. This presents a substantial challenge when patients on high dose opiate therapy require surgery, as opiate pain relief is a cornerstone of postoperative pain management. These patients have exceptionally challenging pain to control. This is likely due to downregulation of existing opiate receptors and the reluctance of clinicians to increase doses of opiates to exceptionally high levels to facilitate pain relief. We hypothesize that using the method of ultra-rapid opiate detoxification (UROD), it would be possible to rapidly increase the number of opiate receptors and return patients to a more naive state, which would be susceptible to exogenous opiate administration. Validation of this hypothesis is supported by two mechanisms, the first of which are reports of patients that underwent UROD for opiate addition that subsequently suffer respiratory arrests when beginning to rapidly abuse opiates shortly after treatment. Additionally there are data demonstrating the tapering of opiate therapy prior to elective surgery results in better pain control. In conclusion, we hypothesize that patients on chronic high dose opiates could obtain substantially better pain relief if they underwent UROD prior to surgery. This technique could be administered shortly before surgery and may dramatically improve the patients' recoveries. (c) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:529 / 531
页数:3
相关论文
共 22 条
[1]   Opioid-induced hyperalgesia - A qualitative systematic review [J].
Angst, MS ;
Clark, JD .
ANESTHESIOLOGY, 2006, 104 (03) :570-587
[2]  
Brill Silviu, 2013, J Pain Palliat Care Pharmacother, V27, P185, DOI 10.3109/15360288.2013.788605
[3]  
Chern S-YS, 2013, J ANESTH CLIN RES, V3
[4]   ULTRA-LOW CONCENTRATIONS OF NALOXONE SELECTIVELY ANTAGONIZE EXCITATORY EFFECTS OF MORPHINE ON SENSORY NEURONS, THEREBY INCREASING ITS ANTINOCICEPTIVE POTENCY AND ATTENUATING TOLERANCE DEPENDENCE DURING CHRONIC COTREATMENT [J].
CRAIN, SM ;
SHEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10540-10544
[5]   General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial [J].
De Jong, CAJ ;
Laheij, RJF ;
Krabbe, PFM .
ADDICTION, 2005, 100 (02) :206-215
[6]  
Favrat B, 2006, JAMA-J AM MED ASSOC, V295, P885, DOI 10.1001/jama.295.8.885-a
[7]   Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: A randomised clinical trial [J].
Favrat, B ;
Zimmermann, G ;
Zullino, D ;
Krenz, S ;
Dorogy, F ;
Muller, J ;
Zwahlen, A ;
Broers, B ;
Besson, J .
DRUG AND ALCOHOL DEPENDENCE, 2006, 81 (02) :109-116
[8]   Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia:: A comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns [J].
Kienbaum, P ;
Scherbaum, N ;
Thürauf, N ;
Michel, MC ;
Gastpar, M ;
Peters, J .
CRITICAL CARE MEDICINE, 2000, 28 (04) :969-976
[9]   Opioid-induced hyperalgesia. Pathophysiology and clinical relevance [J].
Koppert, W .
ANAESTHESIST, 2004, 53 (05) :455-466
[10]   CHRONIC NALOXONE RESULTS IN PROLONGED INCREASES IN OPIATE BINDING-SITES IN BRAIN [J].
LAHTI, RA ;
COLLINS, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (02) :185-186